Share on StockTwits

West Pharmaceutical Services (NYSE:WST) VP Richard D. Luzzi sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $44.07, for a total value of $440,700.00. Following the completion of the transaction, the vice president now directly owns 90,795 shares of the company’s stock, valued at approximately $4,001,336. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of West Pharmaceutical Services in a research note on Tuesday, August 5th. They now have a $45.00 price target on the stock, down previously from $47.00.

Shares of West Pharmaceutical Services (NYSE:WST) remained flat at $44.05 during during mid-day trading trading on Friday. 64,609 shares of the company’s stock traded hands. West Pharmaceutical Services has a one year low of $36.77 and a one year high of $51.12. The stock has a 50-day moving average of $41.21 and a 200-day moving average of $43.32. The company has a market cap of $3.117 billion and a price-to-earnings ratio of 27.84.

West Pharmaceutical Services (NYSE:WST) last released its earnings data on Thursday, July 31st. The company reported $0.52 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.47 by $0.05. The company had revenue of $368.90 million for the quarter, compared to the consensus estimate of $368.60 million. During the same quarter last year, the company posted $0.86 earnings per share. West Pharmaceutical Services’s revenue was up 7.1% compared to the same quarter last year. On average, analysts predict that West Pharmaceutical Services will post $1.84 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Wednesday, November 5th. Stockholders of record on Wednesday, October 22nd will be paid a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a dividend yield of 1.00%.

West Pharmaceutical Services, Inc (NYSE:WST) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries.

Receive News & Ratings for West Pharmaceutical Services Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.